Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 428 of 1,261
  1. US 10632180

    Methods and compositions for improved cognition

    The Regents of the University of California · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  2. US 10632152

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  3. US 10632092

    Composition for and method to increase serum adiponectin and reduce body fat

    FIRST FRUITS BUSINESS MINISTRY, LLC · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  4. US 10632088

    Inactivators of Toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

    Northwestern University · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  5. US 10632101

    Methods and compositions for supporting endogenous systems related to life span

    USANA Health Sciences, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  6. US 10632091

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  7. US 10632070

    Hydrogel toxin-absorbing or binding nanoparticles

    The Regents of the University of California · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  8. US 10631559

    Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-(3S,6S)-

    SUNTORY BEVERAGE & FOOD ASIA PTE. LTD. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  9. US 10632072

    Systems and methods for continuous manufacturing of liposomal drug formulations

    UNIVERSITY OF CONNECTICUT · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  10. US 10633351

    Halogenated compound and axially chiral isomer thereof

    Medshine Discovery Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  11. CA 3116885

    COMPOSITIONS ET METHODES D'ADMINISTRATION DE TRANSGENE

    CRISPR THERAPEUTICS AG [CH] · Granted Apr 23, 2020 · Expires Apr 18, 2040

    granted
  12. US 10626399

    Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  13. US 10624959

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  14. US 10626146

    α4β7 thioether peptide dimer antagonists

    Protagonist Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  15. US 10626129

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  16. US 10626469

    Rapid identification of microorganisms

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  17. US 10626094

    Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  18. US 10624849

    Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

    Northwestern University · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  19. US 10624887

    Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diol

    Relmada Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  20. US 10624850

    Emulsion formulations of an NK-1 receptor antagonist and uses thereof

    Heron Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  21. US 10627409

    Therapeutic antibodies against ROR-1 protein and methods for use of same

    The Regents of the University of California · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  22. US 10626393

    Delivering CRISPR therapeutics with lipid nanoparticles

    ARBUTUS BIOPHARMA CORPORATION · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  23. US 10626145

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  24. US 10626419

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.